RankingsPricing
  1. JP-listed companies
  2. Astellas Pharma Inc.
  3. Financials
  4. Cash from investing

Astellas Pharma Inc.【JP:4503】

Market cap
¥4.19T
P/E ratio
23x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCash from investing (Million JPY)YoY (%)
Mar 31, 2025-89,419-89.43%
Mar 31, 2024-845,802+900.95%
Mar 31, 2023-84,500+35.39%
Mar 31, 2022-62,413-23.79%
Mar 31, 2021-81,894-78.99%
Mar 31, 2020-389,793+833.48%
Mar 31, 2019-41,757-65.72%
Mar 31, 2018-121,799+65.98%
Mar 31, 2017-73,383-50.10%
Mar 31, 2016-147,050+105.73%
Mar 31, 2015-71,476+166.19%
Mar 31, 2014-26,851-51.27%
Mar 31, 2013-55,101

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)